CLYM (Climb Bio Inc) Total Enterprise Value
The price action of Climb Bio Inc (CLYM) on the GURU.Markets platform, where the Enterprise Value stands at 324.20, highlights the high barrier to entry in the sector due to stringent FDA oversight and costly research. Currently, Climb Bio Inc is establishing its reputation as an immunology expert while awaiting verdicts on its assets. The stability of results is ensured by the streamlined transport of biosamples during testing.
Climb Bio Inc (CLYM) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Climb Bio Inc. (CLYM)
The selection of high-quality issuers is based on business valuation analysis, where the summation of market capitalization and net debt determines the actual asset buyout threshold. The indicative enterprise value level reflects the actual price of Climb Bio Inc (CLYM), accounting for the costs of recruiting clinical experts and the stability of the scientific staff, which allows for an assessment of the pipeline capitalization without distortions from debt obligations.
Competitor analysis for Climb Bio Inc
ARGX - Total Company Value|BNTX (BioNTech Group) - Real Price to Acquire Entire Company|ABVX: Total Enterprise Value|ADMA (ADMA Biologics) - Total Company Value|PTGX (protagonist-inc.com) - Real Price to Acquire Entire Company|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|ENGN: Enterprise Value|RAPT: Real Price to Acquire Entire Company|aerovatetx.com (JBIO) - Total Company Value|aclaristx.com (ACRS) - Total Company Value|KYTX: Enterprise Value|Company Buyout Price TLSA|Total Company Value CABA (Cabaletta Bio, Inc)|Real Price to Acquire Entire Company Ventyx Biosciences, Inc (VTYX)|Enterprise Value Theratechnologies Inc. THTX|AVTX - Total Company Value|Real Price to Acquire Entire Company Eledon Pharmaceuticals, Inc. (ELDN)|AGEN - Value Adjusted for Debt and Cash|Zura Bio (ZURA) - Enterprise Value|aTyr Pharmaceuticals (ATYR) - Total Company Value|ADAG: Enterprise Value|Company Buyout Price IMA|Shattuck Labs, Inc. - Total Company Value|Total Enterprise Value equilliumbio.com EQ|Real Price to Acquire Entire Company Connect Biopharma Holdings Limited|Value Adjusted for Debt and Cash Immunic Therapeutics IMUX|Enterprise Value ATRA (Atara Biotherapeutics Inc)|IFRX: Company Buyout Price|Total Company Value X4 Pharmaceuticals, Inc.|Adicet Bio, Inc. (ACET) - Business Value|Enterprise Value CELU|Real Price to Acquire Entire Company INmune Bio Corporation|Enterprise Value BRNS (Barinthus Biotherapeutics)|Real Price to Acquire Entire Company KZR (kezarlifesciences.com)|Total Company Value SAB Biotherapeutics, Inc. SABS|AKTX - Total Company Value|ENLV (Enlivex Therapeutics, Ltd.) - Real Price to Acquire Entire Company|QTTB: Total Enterprise Value|GOVX (GeoVax Labs, Inc.) - Total Company Value|EDSA (edesabiotech.com) - Real Price to Acquire Entire Company|Total Company Value iBio IBIO|Full Business Value Carisma Tx|XTL Biopharmaceuticals, Ltd. (XTLB) - Enterprise Value|Value Adjusted for Debt and Cash boltbio.com (BOLT)|Enterprise Value HCWB (HCW Biologics)|Aptevo Therapeutics, Inc. - Enterprise Value|Total Company Value AIM ImmunoTech Inc. (AIM)|ADTX: Value Adjusted for Debt and Cash|GRI (GRI Bio Corp) - Total Company Value|XORTX Corp (XRTX) - Real Price to Acquire Entire Company|HIND (Vyome Holdings Inc) - Enterprise Value|Enterprise Value revbiosciences.com (REVB)|Indaptus Therapeutics, Inc. (INDP) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Scinai Immunotherapeutics Ltd (SCNI)|Enterprise Value CALI|Affimed NV - Company Buyout Price|ALLK: Total Company Value|HOOK: Real Price to Acquire Entire Company|IGMS (igmbio.com) - Total Company Value|Real Price to Acquire Entire Company iTeos Therapeutics Inc|OCEA (Ocean Bio) - Real Price to Acquire Entire Company|Enterprise Value TCBP|Total Company Value Third Harmonic Bio THRD